Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage
Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care.
Health Experts Warn of ‘Devastating’ Impact After Senate Rejects ACA Tax Credit Extension
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups that the move will sharply raise premiums and reduce affordable coverage.
Beyond Analytics: How Sellers Dorsey is Hard-Coding Value into Medicaid Policy [Video]
How to turn analytics into actual policy outcomes.
6 Things to Know About Trump’s New CDC Director Pick
President Donald Trump selected Susan Monarez — the current acting director of the Centers for Disease Control and Prevention — to lead the agency going forward. This nomination replaces one that the White House withdrew on March 13, after it became clear that physician and former Republican congressman Dave Weldon would not receive enough Senate votes to be confirmed.
‘Increasingly Concerned’ Senators Launch Investigation Into Private Equity’s Effect on Healthcare
This week, two bipartisan members of the Senate Budget Committee launched an investigation into private equity and its impact on healthcare. They initiated the probe to get answers about “questionable financial transactions” that could be hurting care quality for patients at hospitals owned by private equity firms.
More Than 60 Groups Ask Senate Leadership To Pass Legislation To Lower Drug Prices
In a letter to Senate leadership, several organizations asked for the passing of legislation that would reform the patent system and improve competition in the prescription drug space.
Senators Introduce Bipartisan Bill To Impose Harsher Penalties On Those Who Assault Healthcare Staff
This week, senators introduced a bipartisan bill that would make it a federal crime to assault hospital workers. Even though nearly 40 states have passed laws to intensify penalties for violent acts committed against healthcare personnel, there is currently no federal law protecting hospital employees from assault or intimidation.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Senate Bill Proposes Slashing ‘Red Tape’ Around Biosimilar Interchangeability
Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.
Senate Finance Committee Advances Bill Targeting PBMs
The Senate Finance Committee voted 26-1 to advance the Modernizing and Ensuring PBM Accountability Act. The bill has several provisions, including delinking PBM income from prescription drug prices under Medicare Part D and banning spread pricing in Medicaid.
Senators pick two telehealth policy changes that should stay
During a Monday hearing, the Senate Committee on Health, Education, Labor and Pensions discussed which changes to telehealth coverage made during the Covid-19 pandemic should stay.
Lawmakers introduce dueling Covid-19 privacy bills
Congressional Democrats and Republicans introduced privacy bills that attempt to rein in what companies can do with data collected during the Covid-19 pandemic.
presented by
Survey on the Healthcare Financial Landscape Offers a Roadmap for Stakeholders
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Senators threaten to subpoena Cigna in insulin cost probe
Senators Chuck Grassley and Ron Wyden are demanding that Cigna turn over documents on insulin pricing, as part of a larger probe on rising insulin costs. The lawmakers claim that large pharmacy benefit manager Express Scripts, which Cigna acquired in 2018, is failing to comply with the investigation.
Senators urge greater FTC scrutiny over large biopharma mergers
Nine senators sent a letter to FTC Chairman Joseph Simons urging greater scrutiny over like the one between BMS and Celgene, expressing concern over antitrust issues, innovation and drug pricing.
Senators urge action in Novartis gene therapy data manipulation scandal
Five Democratic senators - two running for president - wrote in a letter to the FDA's acting commissioner that the scandal highlighted industry "privilege and greed."
Senate committee panel puts drug industry CEOs on defensive over pricing
The Senate Finance Committee grilled executives from seven of the biggest drugmakers about the dramatic rise in drug costs.
Senate Democrats say Novartis’s deal with Trump attorney Michael Cohen more extensive than reported
Novartis spokesperson says company cooperated with inquiries and disputes conclusions in the report.